noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

United States Attorney's Office[...]

Five Repeat Felons Sentenced To Prison For Illegal Firearm Possession[...]
Kevin Cramer

DOT Awards $2.4 Million to Dickinson Airport
Ross Stores Inc.

Statement of Changes in Beneficial Ownership (Form 4)

Healthcare

Raphael Pharmaceutical Inc.

03/24/2026 | Press release | Distributed by Public on 03/24/2026 14:01

Management Change/Compensation (Form 8-K)

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensation Arrangements of Certain Officers.

On December 31, 2025, the term of service of Dr. Yehuda Eliya as a member of the Board of Directors (the "Board") of the Company expired, and he ceased to serve as a director of the Company effective as of such date.

Dr. Eliya's departure from the Board was not the related to any disagreement with the Company on any matter relating to the Company's operations, policies or practices.

Raphael Pharmaceutical Inc. published this content on March 24, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on March 24, 2026 at 20:01 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]

Back

View original format